Aveanna Healthcare Holdings ROE 2020-2026 | AVAH
Current and historical return on equity (ROE) values for Aveanna Healthcare Holdings (AVAH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Aveanna Healthcare Holdings ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2026-06-30 | $0.28B | $0.18B | 150.68% |
| 2026-03-31 | $0.26B | $0.11B | 243.16% |
| 2025-12-31 | $0.23B | $0.02B | 989.01% |
| 2025-09-30 | $0.08B | $-0.06B | -132.16% |
| 2025-06-30 | $0.02B | $-0.10B | -18.37% |
| 2025-03-31 | $0.01B | $-0.13B | -4.01% |
| 2024-12-31 | $-0.01B | $-0.13B | 8.22% |
| 2024-09-30 | $-0.07B | $-0.14B | 48.80% |
| 2024-06-30 | $-0.13B | $-0.12B | 101.83% |
| 2024-03-31 | $-0.11B | $-0.10B | 119.26% |
| 2023-12-31 | $-0.13B | $-0.07B | 192.11% |
| 2023-09-30 | $-0.35B | $-0.04B | 892.90% |
| 2023-06-30 | $-0.22B | $0.05B | -491.62% |
| 2023-03-31 | $-0.72B | $0.10B | -746.11% |
| 2022-12-31 | $-0.66B | $0.27B | -243.75% |
| 2022-09-30 | $-0.55B | $0.43B | -127.40% |
| 2022-06-30 | $-0.57B | $0.56B | -101.60% |
| 2022-03-31 | $-0.10B | $0.70B | -13.98% |
| 2021-12-31 | $-0.12B | $0.60B | -19.42% |
| 2021-09-30 | $0.00B | $0.51B | -0.20% |
| 2021-06-30 | $-0.01B | $0.32B | -3.11% |
| 2021-03-31 | $-0.09B | $0.13B | -66.29% |
| 2020-12-31 | $-0.06B | $0.07B | -86.04% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $3.112B | $2.433B |
| Aveanna Healthcare Holdings Inc. is a diversified home care platform focused on providing care to medically complex, high-cost patient populations. Aveanna Healthcare Holdings Inc. is based in Atlanta, Georgia. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.874B | 13.39 |
| Quest Diagnostics (DGX) | United States | $27.271B | 23.22 |
| DaVita (DVA) | United States | $12.368B | 15.15 |
| Encompass Health (EHC) | United States | $12.224B | 21.22 |
| Elanco Animal Health (ELAN) | United States | $11.421B | 21.57 |
| Chemed (CHE) | United States | $6.665B | 23.76 |
| RadNet (RDNT) | United States | $5.964B | 172.23 |
| LifeStance Health (LFST) | United States | $4.888B | 98.39 |
| Option Care Health (OPCH) | United States | $3.665B | 15.49 |
| Addus HomeCare (ADUS) | United States | $2.213B | 20.02 |
| Astrana Health (ASTH) | United States | $2.101B | 22.31 |
| Pennant (PNTG) | United States | $1.484B | 38.62 |
| U.S Physical Therapy (USPH) | United States | $1.244B | 32.83 |
| Daxor (DXR) | United States | $0.068B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.022B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |